L. Julou

发表

J. Blanchard, A. Boireau, L. Julou, 1982, International pharmacopsychiatry.

Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortical systems

J. Glowinski, B. Scatton, A. Boireau, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacological and clinical studies of cyclopyrrolones: Zopiclone and suriclone

J. Dreyfus, J. Blanchard, L. Julou, 1984, Pharmacology Biochemistry and Behavior.

Suriclone: A New Cyclopyrrolone Derivative Recognizing Receptors Labeled by Benzodiazepines in Rat Hippocampus and Cerebellum

J. Blanchard, L. Julou, Louis Julou, 1983, Journal of neurochemistry.

Chapter 3 Pharmacology

L. Julou, J. Boissier, D. H. Tedeschi, 1970 .

Pharmacological studies on zopiclone.

J. Stutzmann, J. Blanchard, L. Julou, 1982, International pharmacopsychiatry.

The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors--I. In vitro studies.

J. Blanchard, A. Boireau, L. Julou, 1980, Biochemical pharmacology.

[Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].

R. Ducrot, G. Werner, P. Populaire, 1967, Pathologie et biologie.

Hypotensive activity of PAF-acether in rats

L. Julou, J. L. Zundel, C. Caillard, 1982, Agents and Actions.

Acute and subacute effects of neuroleptics on dopamine synthesis and release in the rat striatum

B. Scatton, L. Julou, C. Garret, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat.

J. Glowinski, S. Kety, A. Thierry, 1967, Proceedings of the National Academy of Sciences of the United States of America.

Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics

J. Glowinski, B. Scatton, L. Julou, 1976, Brain Research.

Ketoprofen (19.583 R.P.) (2-(3-benzoylphenyl)-propionic acid). Main pharmacological properties--outline of toxicological and pharmacokinetic data.

R. Ducrot, L. Julou, J. Pasquet, 1976, Scandinavian journal of rheumatology. Supplement.

In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors.

C Garret, J C Blanchard, A Boireau, 1979, Life sciences.

Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock.

J. Glowinski, S. Kety, J. Musacchio, 1969, Proceedings of the National Academy of Sciences of the United States of America.

[The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections].

L. Julou, C. Cosar, 1959, Annales de l'Institut Pasteur.

PHARMACOLOGICAL STUDY OF PIPOTIAZINE (19.366 R. P.) AND ITS UNDECYLENIC (19.551 R.P.) AND PALMITIC (19.552 R.P.) ESTERS: Main Data Concerning Distribution and Metabolsm of the Esters in the Rat

R. Ducrot, L. Julou, C. Garret, 1973, Acta psychiatrica Scandinavica. Supplementum.

Activity of (Hydroxy-2'Ethyl)-1 Methyl- 2 Nitro-5 Imidazole (8823, R.P.) in Experimental Trichomonas vaginalis Infections.

L. Julou, C. Cosar, 1959 .

Differences between cyclopyrrolones (suriclone and zopiclone) and benzodiazepine binding to rat hippocampus photolabelled membranes.

J. Blanchard, L. Julou, J. L. Zundel, 1983, Biochemical pharmacology.

Effects of thioproperazine and apomorphine on dopamine synthesis in the mesocortical dopaminergic systems

J. Glowinski, A. Thierry, B. Scatton, 1975, Brain Research.

The neuroleptics. 4. Toxicity and side effects in man and in the laboratory animal.

W. Meier-Ruge, L. Hollister, L. Julou, 1970, Modern problems of pharmacopsychiatry.

[Experimental study on metronidazole (RP-8823. Trichomonacidal and amebicidal activities. Toxicity and general pharmacological properties].

L. Julou, P. Ganter, C. Cosar, 1961, La Presse medicale.

Suriclone, a new anxiolytic of the cyclopyrrolone family: evidence for possible interference with GABAergic systems.

J. Stutzmann, J. Blanchard, A. Boireau, 1984, European journal of pharmacology.

2319 – BENZODIAZEPINE-LIKE CENTRAL EFFECTS OF R.P. 27 267, A DIHYDRO-7-OXO-5H-PYRROLO [3,4-b] PYRAZINE DERIVATIVE

R. Ducrot, L. Julou, C. Garret, 1978 .

The neuroleptics. 3. Pharmacology. Introduction.

J. V. van Rossum, L. Julou, J. Boissier, 1970, Modern problems of pharmacopsychiatry.

[STUDY OF THE GENERAL PHARMACOLOGICAL PROPERTIES OF 3-CYANO-10-(3-(4-HYDROXY-1-PIPERIDYL)-PROPYL)-PHENOTHIAZINE OR PROPERICIAZINE (RP 8909)].

R. Ducrot, L. Julou, S. Courvoisier, 1963, Comptes rendus des seances de la Societe de biologie et de ses filiales.

Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.

J. Glowinski, B. Scatton, L. Julou, 1977, Advances in biochemical psychopharmacology.

Receptor binding methods: application to the study of cyclopyrrolones, a new family of minor tranquillizers

J. Blanchard, L. Julou, 1983 .

Partial chemical characterization of cyclopyrrolones ([3H] suriclone) and benzodiazepines ([3H]flunitrazepam) binding site: differences.

J. Blanchard, L. Julou, J. L. Zundel, 1985, Life sciences.

The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors--II. In vivo studies.

J. Blanchard, A. Boireau, L. Julou, 1980, Biochemical Pharmacology.

Studies on the immunosuppressive activity of L-asparaginase.

G. Werner, L. Julou, Y. de Ratuld, 1970, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.